|
|
|
|
|
|
|
|
|
|
Super Quote | Detail Quote | Interactive Chart | Transaction | Related News | Related Securities | Company Information | Dividend Records | Short Sell
03759 PHARMARON
Nominal 
14.000 0.000 (0.000%) | 2024/06 - Interim RMB(K¥) | 2023/12 RMB(K¥) | 2022/12 RMB(K¥) | 2021/12 RMB(K¥) | 2020/12 RMB(K¥) | |
| Net Cash from / (used in) Operating Activities | -- | 2,753,539 | 2,142,816 | 2,058,044 | 1,648,610 |
| Net Cash from / (used in) Investing Activities | -- | (2,250,833) | (2,208,542) | (5,258,147) | (3,371,051) |
| Net Cash from / (used in) Financing Activities | -- | 3,915,262 | (1,417,262) | 3,661,395 | (280,178) |
| Increase / (Decrease) in Cash & Cash Equivalents | -- | 4,417,968 | (1,482,988) | 461,292 | (2,002,619) |
| Cash & Cash Equivalents at beginning of period | -- | 1,359,713 | 2,769,708 | 2,353,933 | 4,442,218 |
| Effect of Foreign Exchange Rate Changes | -- | 11,434 | 72,993 | (45,516) | (85,666) |
| Others | -- | 0 | 0 | 0 | 0 |
| Cash & Cash Equivalents at end of period | -- | 5,789,115 | 1,359,713 | 2,769,709 | 2,353,933 |
| Remarks: | Real time quote last updated: 22/11/2024 07:51 |
| Real-time basic market prices of Hong Kong securities are provided by HKEx; a Designated Website authorized by the HKEx Group to provide the Service | |
| Profit / (Loss) Attributable to Shareholders (K¥) | RMB 1,113,403 |
| %Change | 41.638% |
| EPS / (LPS) | RMB 0.628 |
| NBV Per Share (¥) | RMB 7.280 |